Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2006-02-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.0508476103PMID 16492744PMCID PMC1413884
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development.

  2006cited by this paper
• Tissue-Specific Differences of p53 Inhibition by Mdm2 and Mdm4

  2006cited by this paper
• Mdmx as an essential regulator of p53 activity.

  2005cited by this paper
• Death squads enlisted by the tumour suppressor p53.

  2005cited by this paper
• G1 checkpoint failure and increased tumor susceptibility in mice lacking the novel p53 target Ptprv

  2005cited by this paper
• Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2

  2003cited by this paper
• mdm2 Is Critical for Inhibition of p53 during Lymphopoiesis and the Response to Ionizing Irradiation

  2003cited by this paper
• HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53

  2003cited by this paper
• Conditional allele of mdm2 which encodes a p53 inhibitor

  2002cited by this paper
• Live or let die: the cell's response to p53

  2002cited by this paper
• Mdm4 (Mdmx) Regulates p53-Induced Growth Arrest and Neuronal Cell Death during Early Embryonic Mouse Development

  2002cited by this paper
• 1-Class Integrins Regulate the Development of Laminae and Folia in the Cerebral and Cerebellar Cortex

  2001cited by this paper
• Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells

  2001cited by this paper
• Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53

  2001cited by this paper
• Neuronal Basic Helix-Loop-Helix Proteins (NEX and BETA2/Neuro D) Regulate Terminal Granule Cell Differentiation in the Hippocampus

  2000cited by this paper
• Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase

  2000cited by this paper
• Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids.

  2000cited by this paper
• Stabilization of the MDM2 Oncoprotein by Interaction with the Structurally Related MDMX Protein*

  1999cited by this paper
• Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety

  1999cited by this paper
• MDM2 expression during mouse embryogenesis and the requirement of p53.

  1998cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997cited by this paper
• Regulation of p53 stability by Mdm2

  1997cited by this paper
• Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

  1997cited by this paper
• MDMX: a novel p53‐binding protein with some functional properties of MDM2.

  1996cited by this paper
• Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53

  1995cited by this paper
• Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53

  1995cited by this paper
• Tumor spectrum analysis in p53-mutant mice.

  1994cited by this paper
• mdm2 expression is induced by wild type p53 activity.

  1993cited by this paper
• Mapping of the p53 and mdm-2 interaction domains.

  1993cited by this paper
• Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis.

  1993cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• The p53-mdm-2 autoregulatory feedback loop.

  1993cited by this paper
• The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

  1992cited by this paper

• Effect of whole-plant mulberry supplementation on testis development and antioxidant capacity in Hu rams

  2025cites this paper
• The MDM4 Inhibitor CEP-1347 Activates Wild-type p53 in Ovarian Clear Cell Carcinoma Cells and Potently Inhibits their Growth

  2025cites this paper
• The key vulnerabilities and therapeutic opportunities in the USP7-p53/MDM2 axis in cancer.

  2025cites this paper
• Microgravity Impacts the Expression of Aging-Associated Candidate Gene Targets in the p53 Regulatory Network

  2025cites this paper
• Harnessing p53 for targeted cancer therapy: new advances and future directions

  2025cites this paper
• Targeting p53 activation: Recent therapeutic advances in cancer and diabetic macular edema.

  2025cites this paper
• EV-miRNAs from breast cancer patients of plasma as potential prognostic biomarkers of disease recurrence

  2024cites this paper
• Nucleo-cytoplasmic environment modulates spatiotemporal p53 phase separation

  2024cites this paper
• Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition.

  2024cites this paper
• First reported advanced pancreatic cancer with hyperprogression treated with PD-1 blockade combined with chemotherapy: a case report and literature review

  2024cites this paper
• Cellular, Structural Basis, and Recent Progress for Targeting Murine Double Minute X (MDMX) in Tumors.

  2024cites this paper
• The role of 1q abnormalities in multiple myeloma: Genomic insights, clinical implications, and therapeutic challenges.

  2024cites this paper
• Targeting protein-protein interactions in drug discovery: Modulators approved or in clinical trials for cancer treatment.

  2024cites this paper
• The Role of Glycogen Synthase Kinase-3β in the Zinc-Mediated Neuroprotective Effect of Metformin in Rats with Glutamate Neurotoxicity

  2023cites this paper
• p53 amyloid pathology with cancer grades and p53 mutations

  2023cites this paper
• Ribosome subunit attrition and activation of the p53–MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition

  2023cites this paper
• Deletion of ARGLU1 causes global defects in alternative splicing in vivo and mouse cortical malformations primarily via apoptosis

  2023cites this paper
• Tissue specificity and spatio-temporal dynamics of the p53 transcriptional program

  2023cites this paper
• Tau protein binds to the P53 E3 ubiquitin ligase MDM2

  2023cites this paper
• p53 amyloid pathology is correlated with cancer grades irrespective of the mutant or wildtype forms.

  2023cites this paper
• Review: MDMX plays a central role in leukemic transformation and may be a promising target for leukemia prevention strategies.

  2023cites this paper
• MDMX Regulates Transcriptional Activity of p53 and FOXO Proteins to Stimulate Proliferation of Melanoma Cells

  2022cites this paper
• Circular RNA CCDC66 Improves Murine Double Minute 4 (MDM4) Expression through Targeting miR-370 in Colorectal Cancer

  2022cites this paper
• miR-1307-5p suppresses proliferation and tumorigenesis of bladder cancer via targeting MDM4 and the Hippo signaling pathway

  2022cites this paper
• MDM4: What do we know about the association between its polymorphisms and cancer?

  2022cites this paper
• Whole-genome analysis of human embryonic stem cells enables rational line selection based on genetic variation

  2022cites this paper
• Two short linear motifs in the MDMX acidic domain bind overlapping sites on MDMX and p53.

  2022cites this paper
• The roles of mouse double minute 2 (MDM2) oncoprotein in ocular diseases: A review.

  2022cites this paper
• MDMX elevation by a novel Mdmx–p53 interaction inhibitor mitigates neuronal damage after ischemic stroke

  2022cites this paper
• Parkin interacting substrate phosphorylation by c-Abl drives dopaminergic neurodegeneration.

  2021cites this paper
• Lin28a rejuvenates muscle stem cells via mitochondrial optimization

  2021cites this paper
• Mechanisms of TP53 Pathway Inactivation in Embryonic and Somatic Cells—Relevance for Understanding (Germ Cell) Tumorigenesis

  2021cites this paper
• MDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53

  2021cites this paper
• Investigational new drugs against glioblastoma

  2021cites this paper
• The Efficacy of siRNA Specific MDM2 in the Induction of Apoptosis in MCF-7 Breast Cancer Cell Line

  2021cites this paper
• Pharmacokinetic–pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies

  2021cites this paper
• Proximity-induced amino-yne reaction for selective MDM4 conjugation via propargylated sulfonium

  2021cites this paper
• Targeting mechanosensitive MDM4 promotes lung fibrosis resolution in aged mice

  2021cites this paper
• Recent Progress and Clinical Development of Inhibitors that Block MDM4/p53 Protein-Protein Interactions.

  2021cites this paper
• Case Report: MDM4 Amplified in a Thymoma Patient With Autoimmune Enteropathy and Myocarditis

  2021cites this paper
• MDM4 as a Prognostic Factor for Patients With Gastric Cancer With Low Expression of p53

  2021cites this paper
• Mdm4 controls ureteric bud branching via regulation of p53 activity.

  2020influential citation
• USP7 Is a Master Regulator of Genome Stability

  2020cites this paper
• Biological insights from the whole genome analysis of human embryonic stem cells

  2020cites this paper
• Parallel CRISPR-Cas9 screens clarify impacts of p53 on screen performance

  2020cites this paper
• MDMX Recruits UbcH5c to Facilitate MDM2 E3 Ligase Activity and Subsequent p53 Degradation In Vivo

  2020cites this paper
• Genome-wide interrogation of gene functions through base editor screens empowered by barcoded sgRNAs

  2020cites this paper
• Improving cancer therapy with new p53-activating agents

  2019cites this paper
• MDM2/P53 Inhibitors as Sensitizing Agents for Cancer Chemotherapy

  2019cites this paper
• p53 Phosphomimetics Preserve Transient Secondary Structure but Reduce Binding to Mdm2 and MdmX

  2019cites this paper
• Function Analysis of Human Protein Interactions Based on a Novel Minimal Loop Algorithm

  2019cites this paper
• Aloe emodin induces hepatotoxicity by activating NF-κB inflammatory pathway and P53 apoptosis pathway in zebrafish.

  2019cites this paper
• The long and the short of it: the MDM4 tail so far

  2019cites this paper
• Inhibition of p53 inhibitors: progress, challenges and perspectives

  2019cites this paper
• p53 plays a crucial role in endothelial dysfunction associated with hyperglycemia and ischemia.

  2019cites this paper
• Calculation of hot spots for protein–protein interaction in p53/PMI‐MDM2/MDMX complexes

  2018cites this paper
• Cellular and molecular mechanisms of sarcopenia: the S100B perspective

  2018cites this paper
• MDMX acidic domain inhibits p53 DNA binding in vivo and regulates tumorigenesis

  2018cites this paper
• Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia

  2018cites this paper
• Inhibition of Mdmx (Mdm4) in vivo induces anti-obesity effects

  2018cites this paper
• The role of DNA methylation in human trophoblast differentiation

  2018cites this paper
• Activation of the p53-MDM4 regulatory axis defines the anti-tumour response to PRMT5 inhibition through its role in regulating cellular splicing

  2018cites this paper
• The role of MDM2 and MDM4 in breast cancer development and prevention

  2017cites this paper
• Indispensable role of Mdm2/p53 interaction during the embryonic and postnatal inner ear development

  2017cites this paper
• Inhibition of MDM2 by a Rhein-Derived Compound AQ-101 Suppresses Cancer Development in SCID Mice

  2017cites this paper
• When the guardian sleeps: Reactivation of the p53 pathway in cancer.

  2017cites this paper
• Mdm proteins: critical regulators of embryogenesis and homoeostasis

  2017influential citation
• Postmitotic state of a cell as a challenge for regeneration: inner ear as a model

  2017cites this paper
• Mouse modelling of the MDM2/MDMX−p53 signalling axis

  2017cites this paper
• Alterations in Gene Expression and Sensitivity to Genotoxic Stress Following HdmX or Hdm2 Knockdown in Human Tumor Cells Harboring Wild-Type p53

  2017cites this paper
• PIG3 Regulates p53 Stability by Suppressing Its MDM2-Mediated Ubiquitination

  2017influential citation
• The MDMX (MDM4) oncoprotein as a therapeutic target and determinant of response to MDM2-p53 binding antagonists in human cancer

  2017cites this paper
• In Vivo Discoveries in MDM2-Mediated p53 Regulation

  2017cites this paper
• Mdm2 Is Required for Survival and Growth of p53-Deficient Cancer Cells.

  2017cites this paper
• Eukaryotic transcription factors: paradigms of protein intrinsic disorder.

  2017cites this paper
• Dabrafenib inhibits the growth of BRAF‐WT cancers through CDK16 and NEK9 inhibition

  2017cites this paper
• Targeting MDM4 Splicing in Cancers

  2017cites this paper
• Podozyten-spezifischer Murine Double Minute (MDM) 2 Knockout führt zu fokal segmentaler Glomerulosklerose

  2017cites this paper
• Polymorphism in ANRIL is associated with relapse in patients with multiple myeloma after autologous stem cell transplant

  2017cites this paper
• Human and Epstein-Barr Virus miRNA Profiling as Predictive Biomarkers for Endemic Burkitt Lymphoma

  2017cites this paper
• Secondary interaction between MDMX and p53 core domain inhibits p53 DNA binding

  2016cites this paper
• Intra molecular interactions in the regulation of p53 pathway.

  2016cites this paper
• MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and Beyond.

  2016influential citation
• Clinical Overview of MDM2/X-Targeted Therapies

  2016cites this paper
• MDM2 inhibition rescues neurogenic and cognitive deficits in a mouse model of fragile X syndrome

  2016cites this paper
• Oncogenes and Tumor Suppressors p 53 Activity Dominates That of p 73 upon Mdm 4 Loss in Development and Tumorigenesis

  2016cites this paper
• Attenuating the p53 Pathway in Human Cancers: Many Means to the Same End.

  2016cites this paper
• Distinct downstream targets manifest p53-dependent pathologies in mice

  2016cites this paper
• MDM2 oligomers: antagonizers of the guardian of the genome

  2016cites this paper
• MDMX under stress: the MDMX-MDM2 complex as stress signals hub.

  2016cites this paper
• Cerebellum Development and Tumorigenesis: A p53-Centric Perspective.

  2016cites this paper
• L'oncogène Mdm2 : nouvelles fonctions et implications dans le métabolisme des cellules cancéreuses

  2016cites this paper
• The Enigma of p53.

  2016cites this paper
• High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome.

  2016cites this paper
• BAC transgenic mice provide evidence that p53 expression is highly regulated in vivo

  2015cites this paper
• Mechanisms of p53 degradation.

  2015cites this paper
• p53 Activity Dominates That of p73 upon Mdm4 Loss in Development and Tumorigenesis

  2015cites this paper
• Regulation of the p53 response and its relationship to cancer.

  2015cites this paper
• Autoinhibition of MDMX by intramolecular p53 mimicry

  2015cites this paper
• Caspase-dependent degradation of MDMx/MDM4 cell cycle regulatory protein in amyloid β-induced neuronal damage.

  2015cites this paper